In silico DFT, ADMET and molecular docking studies of novel coumarin-linked pyrazole and quinoline derivatives as antimicrobial and antioxidant agents
Nargis H. Shaikh, Jay B. Maheta, Darshna K. Lakhnotra, Prince A. Dave, Ila M. Ram, Dharmesh N. Sherathia, Dharmesh K. Katariya, Hardik B. Bhatt, Yogesh O. Bhola, Swanti A. Jain · 2026
Read In silico DFT, ADMET and molecular docking studies of novel coumarin-linked pyrazole and quinoline derivatives as antimicrobial and antioxidant agents by Nargis H. Shaikh, Jay B. Maheta, Darshna K. Lakhnotra, Prince A. Dave, Ila M. Ram, Dharmesh N. Sherathia, Dharmesh K. Katariya, Hardik B. Bhatt, Yogesh O. Bhola, Swanti A. Jain (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13444106.txt.
Description
Nargis H. Shaikh and colleagues report a 2026 drug discovery study of ten new coumarin hybrids, five linked to pyrazole and five to quinoline, as antimicrobial and antioxidant candidates amid rising resistance. The team synthesized the compounds, optimized solvents to an 88 percent yield, and tested them against four bacteria and one fungus.
Compound 7a proved most potent in the lab, beating standard drugs at a low inhibitory dose, and matched ascorbic acid as an antioxidant, while compound 7b scored best in computer docking. That mismatch reminds readers that docking predicts rather than proves potency. Safety flags, including high predicted genotoxicity, demand rigorous lab checks before any further development.
Catalog record
| CREATOR | Nargis H. Shaikh, Jay B. Maheta, Darshna K. Lakhnotra, Prince A. Dave, Ila M. Ram, Dharmesh N. Sherathia, Dharmesh K. Katariya, Hardik B. Bhatt, Yogesh O. Bhola, Swanti A. Jain |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 81 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |